Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer

Strahlentherapie und Onkologie

Volumn 183, Issue 1, 2007, Pages 10-16

  Rades, Dirk ^a,b,d   Schulte, Rainer ^a   Yekebas, Emre F ^b   Homann, Nils ^a   Schild, Steven E ^c   Dunst, Juergen ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Esophageal cancer; Radiotherapy; Surgery; Treatment outcome

Indexed keywords

CISPLATIN; FLUOROURACIL; HEMOGLOBIN;

ADULT; ANASTOMOSIS LEAKAGE; ARTICLE; BLEEDING; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; ESOPHAGITIS; ESOPHAGUS CANCER; FATALITY; FEMALE; FISTULA; GENDER; HEART ARRHYTHMIA; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MORBIDITY; MULTIMODALITY CANCER THERAPY; MULTIVARIATE ANALYSIS; NAUSEA AND VOMITING; PHYSICAL PERFORMANCE; PLEURA EFFUSION; PNEUMONIA; RESPIRATORY DISTRESS; RETROSPECTIVE STUDY; SIDE EFFECT; TUMOR LOCALIZATION; UNIVARIATE ANALYSIS;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREVALENCE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33846427692     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-007-1583-7     Document Type: Article

References (29)

1. Adam DJ, Craig SR, Sang CT, et al. Esophagogastrectomy for carcinoma in patients under 50 years of age. J R Coll Surg Edinb 1996;41:371-3.
2. Burmeister BH, Denham JW, O'Brien M, et al. Combined modality therapy for esophageal carcinoma: preliminary results from a large Australasian multicenter study. Int J Radiat Oncol Biol Phys 1995;32:997-1006.
3. Catalano G, Jereczek-Fossa BA, De Pas T, et al. Three-times-daily radiotherapy with induction chemotherapy in locally advanced non-small cell lung cancer. Feasibility and toxicity study. Strahlenther Onkol 2005; 181:363-71.
4. Coia LR, Soffen EM, Schultheiss TE, et al. Swallowing function in patients with esophageal cancer treated with concurrent radiation and chemotherapy. Cancer 1993;71:281-6.
5. Daly JM, Fry WA, Little AG, et al. Esophageal cancer: results of an American College of Surgeons patient care evaluation study. J Am Coll Surg 2000; 190:562-73.
6. Denham JW, Steigler A, Kilmurray J, et al. Relapse patterns after chemo-radiation for carcinoma of the oesophagus. Clin Oncol 2003;15:98-108.
7. Dunst J, Diestelhorst A, Kuhn R, et al. Organ-sparing treatment in muscle-invasive bladder cancer. Strahlenther Onkol 2005;181:632-7.
8. Eguchi R, Ide H, Nakamura T, et al. Analysis of post-operative complications after esophagectomy for esophageal cancer in patients receiving neoadjuvant therapy. Jpn J Thorac Cardiovasc Surg 1999;47:552-8.
9. Ellis FH Jr. Standard resection for cancer of the esophagus and cardia. Surg Oncol Clin N Am 1999;8:279-94.
10. Eloubeidi MA, Desmond R, Arguedas MR, et al. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S. The importance of tumor length and lymph node status. Cancer 2002;95:1434-43.
11. Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer: results of a study of the E.O.R.T.C. World J Surg 1987;11:426-32.
12. Horstmann O, Verreet PR, Becker H, et al. Transhiatal esophagectomy compared with transthoracic resection and systematic lymphadenectomy for the treatment of esophageal cancer. Eur J Surg 1995;161:557-67.
13. Klautke G, Foitzik T, Ludwig K, et al. Neoadjuvant radiochemotherapy in locally advanced gatric cancer. Strahlenther Onkol 2004;180:695-700.
14. Kodaira T, Fuwa N, Itoh Y, et al. Multivariate analysis of treatment outcome in patients with esophageal carcinoma treated with definitive radiotherapy. Am J Clin Oncol 2003;26:392-7.
15. Kumar S, Dimri K, Balachandran P, et al. An audit of postoperative radiotherapy after non-curative resection for cancer of the oesophagus. Clin Oncol 2005;17:352-7.
16. Marnitz S, Kohler C, Fuller J, et al. Uterus necrosis after radiochemotherapy in two patients with advanced cervical cancer. Strahlenther Onkol 2006; 182:45-51.
17. Minsky BD, Neuberg D, Kelsen DP, et al. Final report of Intergroup Trial 0122 (ECOG PE-289, RT0G 90-12): phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus. Int J Radiat Oncol Biol Phys 1999;43:517-23.
18. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002;20:1167-74.
19. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392-400.
20. Rades D, Schild SE, Bahrehmand R, et al. Prognostic factors in the non-surgical treatment of esophageal cancer with radiotherapy or radiochemotherapy: the importance of pre-treatment hemoglobin levels. Cancer 2005; 103:1740-6.
21. Rindani R, Martin CJ, Cox MR. Transhiatal versus Ivor-Lewis esophagectomy: is there a difference? Aust N Z J Surg 1999;69:187-94.
22. Shi X, Yao W, Liu T. Late course accelerated fractionation in radiotherapy of esophageal carcinoma. Radiother Oncol 1999;51:21-6.
23. Stahl M, Stuschke M, Lehmann N, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005;23:2310-7.
24. Sun DR. Ten-year follow up of esophageal cancer treated by radical radiation therapy: analysis of 869 patients. Int J Radiat Oncol Biol Phys 1989; 16:329-34.
25. Vaupel P, Thews O, Mayer A, et al. Oxygenation status of gynecologic tumors: what is the optimal hemoglobin level? Strahlenther Onkol 2002; 178:727-31.
26. Vigneswaran WT, Trastek VF, Pairolero PC, et al. Transhiatal esophagectomy for carcinoma of the esophagus. Ann Thorac Surg 1993;56:838-44.
27. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-7.
28. Windschall A, Ott OJ, Sauer R, et al. Radiation therapy and simultaneous chemotherapy for recurrent cervical carcinoma. Strahlenther Onkol 2005; 181:545-50.
29. Wong R, Malthaner RA, Zuraw L, et al. Combined modality radiotherapy and chemotherapy in nonsurgical management of localized carcinoma of the esophagus: a practice guideline. Int J Radiat Oncol Biol Phys 2003; 55:930-42.